跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Iruden - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Iruden
Approved
STANDARD
Iruden
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ef9407b2192a0b69
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
ef9407b2192a0b69
Drug Approval Philippines Name
Iruden
Product Name
Iruden
Registration Number
DRP-2911-03
Brand Name
Iruden
Generic Name
Phenylephrine hydrochloride + Brompheniramine maleate
Dosage Form
Syrup
Dosage Strength
12.5 mg/4 mg per 5 mL
Manufacturer
Lloyd Laboratories, Inc.
Trader
Eadriex Pharmaceutical Phils., Inc.
Distributor
ECE Pharmaceuticals, Inc.
Issuance Date
24 January 2025
Expiry Date
21 April 2030
Pharmacologic Category
Decongestant/Antihistamine
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ef9407b2192a0b69
Type
Standard
Back to Philippines FDA Approvals